Specialty pharmaceutical drives growth in Pharma: The company reported revenue growth of 22% YoY in pharmaceuticals with specialty, covering radio-pharmaceuticals, and APIs leading the growth. The revenue growth across geographies was also robust. The company is now deriving 89% of revenues from regulated markets in Pharma.